Frontier Capital Management CO LLC Neuronetics, Inc. Transaction History

Frontier Capital Management CO LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 16, 2020	SELL	$1.28 - $4.5 $324,819 - $1.14 Million	-253,765 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$4.03 - $9.22 $99,976 - $228,729	-24,808 Reduced 8.91%	253,765 $1.14 Million
Q3 2019 Nov 14, 2019	BUY	$8.31 - $13.03 $1.92 Million - $3.02 Million	231,414 Added 490.71%	278,573 $2.32 Million
Q2 2019 Aug 14, 2019	SELL	$9.0 - $17.2 $174,555 - $333,594	-19,395 Reduced 29.14%	47,159 $590,000
Q1 2019 May 07, 2019	SELL	$13.6 - $19.58 $58,031 - $83,547	-4,267 Reduced 6.03%	66,554 $1.02 Million

Q4 2018 Jan 25, 2019	BUY	$16.0 - $31.84 $50,048 - $99,595	3,128 Added 4.62%	70,821 $1.37 Million
Q3 2018 Oct 30, 2018	SELL	$24.32 - $37.54 $50,196 - $77,482	-2,064 Reduced 2.96%	67,693 $2.17 Million
Q2 2018 Aug 03, 2018	BUY	$26.61 - $27.78 $1.86 Million - $1.94 Million	69,757 New	69,757 $1.86 Million

18.4M

200

3.6K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $48.6M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Capital Management CO LLC with notifications on news.